The Use of Low-Dose Carvedilol to Improve Hypoglycemia Awareness in Patients With Type 1 Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2019
Price : $35 *
At a glance
- Drugs Carvedilol (Primary)
- Indications Hypoglycaemia
- Focus Therapeutic Use
- 22 Apr 2019 Status changed from not yet recruiting to recruiting.
- 06 Mar 2019 Planned number of patients changed from 20 to 21.
- 06 Feb 2019 Planned End Date changed from 1 Jun 2020 to 1 Dec 2020.